View : 17 Download: 0

Pharmacokinetics and pharmacodynamics of a new reformulated microemulsion and the long-chain triglyceride emulsion of propofol in beagle dogs

Title
Pharmacokinetics and pharmacodynamics of a new reformulated microemulsion and the long-chain triglyceride emulsion of propofol in beagle dogs
Authors
Lee S.-H.Ghim J.-L.Song M.-H.Choi H.-G.Choi B.-M.Lee H.-M.Lee E.-K.Roh Y.-J.Noh G.-J.
Ewha Authors
이은경
SCOPUS Author ID
이은경scopus
Issue Date
2009
Journal Title
British Journal of Pharmacology
ISSN
0007-1188JCR Link
Citation
vol. 158, no. 8, pp. 1982 - 1995
Indexed
SCI; SCIE; SCOPUS WOS scopus
Abstract
Background and purpose: Microemulsion propofol was developed to eliminate lipid solvent-related adverse events of long-chain triglyceride emulsion (LCT) propofol. We compared dose proportionality, pharmacokinetic and pharmacodynamic characteristics of both formulations. Experimental approach: The study was a randomized, two-period and crossover design with 7-day wash-out period. Microemulsion and LCT propofol were administered by zero-order infusion (0.75, 1.00 and 1.25 mg·kg -1·min -1) for 20 min in 30 beagle dogs (male/female = 5/5 for each rate). Arterial samples were collected at preset intervals. The electroencephalographic approximate entropy (ApEn) was used as a measure of propofol effect. Dose proportionality, pharmacokinetic and pharmacodynamic bioequivalence were evaluated by non-compartmental analyses. Population analysis was performed using nonlinear mixed effects modelling. Key results: Both formulations showed dose proportionality at the applied dose range. The ratios of geometric means of AUC last and AUC inf between both formulations were acceptable for bioequivalence, whereas that of C max was not. The pharmacodynamic bioequivalence was indicated by the arithmetic means of AAC (areas above the ApEn time curves) and E 0 (baseline ApEn)-E max (maximally decreased ApEn) between both formulations. The pharmacokinetics of both formulations were best described by three compartment models. Body weight was a significant covariate for V 1 of both formulations and sex for k 21 of microemulsion propofol. The blood-brain equilibration rate constants (k e0, min -1) were 0.476 and 0.696 for microemulsion and LCT propofol respectively. Conclusions and implications: Microemulsion propofol was pharmacodynamically bioequivalent to LCT propofol although pharmacokinetic bioequivalence was incomplete, and demonstrated linear pharmacokinetics at the applied dose ranges. © 2009 The British Pharmacological Society All rights reserved.
DOI
10.1111/j.1476-5381.2009.00509.x
Appears in Collections:
자연과학대학 > 통계학전공 > Journal papers
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE